AVTX today
$8.51+$1.35 (+18.85%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minSymmetric Triangle
Daily trend turns up above $34.46
Key levels
Resistance$9.54
Resistance$8.65
Support$7.71
Support$6.53
Latest news & SEC filings
AnalystWedbush keeps Outperform rating on Avalo Therapeutics, cuts price target to $20
All AVTX news →About Avalo Therapeutics
Avalo Therapeutics is a biotech firm in the clinical phase of drug development, concentrating on therapies for inflammatory conditions driven by the immune system. Its main asset is an antibody that targets IL-1β, which is undergoing mid-stage testing for hidradenitis suppurativa. The company is based in the United States and contracts with outside organizations to produce its biologic programs.
Based on the company's 10-K filed Mar 23, 2026.
Nasdaq · Healthcare
Avalo Therapeutics, Inc. (AVTX)
What Is the Price Target for AVTX?
SEPT Low Target
$10.00
SEPT Mid Target
$37.50
SEPT High Target
$60.00
Analyst Consensus
$37.50
Is AVTX a Buy or Sell Right Now?
Thesis
- •Revenue growing -86.6% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AVTX.
Start Free Trial →Is AVTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$34.38
25
Moat Score
NONE
1/9
Piotroski Score
-4.8
Altman Z-Score
What Is Smart Money Doing with AVTX?
Insider Signal
SELLING
0 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Sullivan Christopher Ryan | officer | Buy | 12,394 | $122K | Sep 16, 2026 |
| Sullivan Christopher Ryan | officer | Sale | 12,394 | $202K | Sep 16, 2026 |
| Sullivan Christopher Ryan | officer | Buy | 10,185 | $82K | Sep 10, 2026 |
| Sullivan Christopher Ryan | officer | Sale | 10,185 | $179K | Sep 10, 2026 |
| Doyle Mittie | officer | Buy | 679 | $5K | Aug 28, 2026 |
| Doyle Mittie | officer | Sale | 679 | $14K | Aug 28, 2026 |
| Doyle Mittie | officer | Buy | 2,875 | $36K | Jun 30, 2026 |
| Doyle Mittie | officer | Buy | 1,779 | $14K | Jun 30, 2026 |
| Doyle Mittie | officer | Sale | 4,654 | $93K | Jun 30, 2026 |
| Riley Jennifer | officer | Sale | 588 | $8K | Jun 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AVTX Growth Story
Revenue YoY
-86.6%
3yr Revenue CAGR
-85.2%
EPS Growth YoY
72.07%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for AVTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AVTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 09:02:55 | $8.29 | 1,535 | $$13K | SELL |
| 09:02:52 | $8.24 | 1,676 | $$14K | SELL |
| 09:02:20 | $8.89 | 1,334 | $$12K | BUY |
| 09:02:20 | $8.89 | 2,176 | $$19K | BUY |
| 09:00:21 | $8.54 | 1,000 | $$9K | SELL |
5 dark pool trades shown · $$66K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for AVTX
PREVIEWSEPT Investing provides real-time options flow tracking for AVTX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $12.5 | Dec 18 | 37 | $$500 | 100 | BLOCK |
| CALL | $7.5 | Dec 18 | 37 | $$560 | 4 | SWEEP |
| CALL | $5 | Nov 20 | 9 | $$1400 | 4 | SWEEP |
3 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Avalo Therapeutics, Inc. (AVTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (8 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AVTX — frequently asked questions
What is AVTX stock price today?
Avalo Therapeutics, Inc. (AVTX) is at $8.51, up 18.85% (+$1.35) at the Nov 11, 2026 close.
Why is AVTX stock moving today?
Latest AVTX news — Nov 6, 2026: Wedbush keeps Outperform rating on Avalo Therapeutics, cuts price target to $20
Why did AVTX stock move on Nov 5, 2026?
Avalo Therapeutics shares closed at $6.63, down 1.92% on volume of about 1.2 million shares, as dilution concerns overshadowed a better-than-expected quarterly report. The company posted a Q3 loss of 34 cents per share, well below the 61-cent loss analysts projected, but also filed a mixed shelf offering prospectus and an automatic shelf registration, including a prospectus for a $200 million common share offering.
What is the AVTX price target?
The average analyst price target for AVTX is $37.50, ranging from $10 to $60, based on 10 analysts. Latest: Wedbush maintains on Nov 6, 2026.
What do analysts rate AVTX?
Analyst ratings for AVTX: 0 Buy, 16 Hold, 3 Sell — consensus Hold.
Did AVTX beat earnings?
AVTX last reported on Nov 5, 2026: EPS -$0.34 vs -$0.59 expected — a beat of 42.2%.
Does AVTX pay a dividend?
AVTX does not currently pay a dividend.
What are AVTX support and resistance levels?
Support: $7.71, $6.53, $5.47. Resistance: $8.65, $9.54, $11.21.
What are insiders doing with AVTX?
Insider activity: SELLING, 0 buys and 5 sells in the last 90 days.
What is the latest news on AVTX?
Nov 6, 2026: Wedbush keeps Outperform rating on Avalo Therapeutics, cuts price target to $20